Cellectar (CLRB) CFO awarded 92,000 stock options at $3.14 strike price
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Kolean Chad J reported acquisition or exercise transactions in this Form 4 filing.
Cellectar Biosciences CFO Chad J. Kolean received a grant of 92,000 stock options to buy common shares at $3.14 per share. The options were contingently granted on May 28, 2026, under Cellectar's amended 2021 Stock Incentive Plan and became effective after stockholders approved the plan on July 7, 2026.
The award vests over three years from May 28, 2026, with one-third vesting on the first anniversary and the remaining two-thirds vesting in 24 equal monthly installments thereafter. Following this grant, Kolean holds 92,000 stock options directly under this award.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Kolean Chad J
Role
CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 92,000 | $0.00 | -- |
Holdings After Transaction:
Stock option (right to buy) — 92,000 shares (Direct, null)
Footnotes (1)
- This option was contingently granted on May 28, 2026, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2026 Annual Meeting of Stockholders. Such stockholder approval was obtained on July 7, 2026. This option shall vest over a period of three years from May 28, 2026, with 1/3 vesting on the first anniversary of May 28, 2026, and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of May 28, 2026.
Key Figures
Option grant size: 92,000 options
Exercise price: $3.14 per share
Options held after grant: 92,000 options
+3 more
6 metrics
Option grant size
92,000 options
Grant to CFO Chad J. Kolean
Exercise price
$3.14 per share
Stock option exercise price
Options held after grant
92,000 options
Total from this award following transaction
Option expiration
May 28, 2036
Option expiration date
Grant start date
May 28, 2026
Reference date for vesting schedule
Shareholder approval date
July 7, 2026
Plan approval making contingent grant effective
Key Terms
2021 Stock Incentive Plan, Annual Meeting of Stockholders, stock option (right to buy), vest, +1 more
5 terms
2021 Stock Incentive Plan financial
"subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan"
Annual Meeting of Stockholders regulatory
"at Cellectar's 2026 Annual Meeting of Stockholders"
stock option (right to buy) financial
"security_title: Stock option (right to buy)"
vest financial
"This option shall vest over a period of three years"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
common stock financial
"underlying_security_title: Common stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transaction did Cellectar Biosciences (CLRB) report for its CFO?
Cellectar Biosciences reported a compensation-related grant of 92,000 stock options to CFO Chad J. Kolean. The options allow him to buy common stock at $3.14 per share, contingent on prior shareholder approval of the amended 2021 Stock Incentive Plan.
What is the exercise price and size of the Cellectar (CLRB) CFO option grant?
CFO Chad J. Kolean received stock options for 92,000 shares at an exercise price of $3.14 per share. These options relate to Cellectar’s common stock and were granted as part of the company’s amended 2021 Stock Incentive Plan.
How do the Cellectar (CLRB) CFO stock options vest over time?
The 92,000 stock options granted to Cellectar’s CFO vest over three years from May 28, 2026. One-third vests on the first anniversary, and the remaining two-thirds vest in 24 equal monthly installments starting on that first anniversary date.